Internationally renowned R&D centers

With an open innovation model in mind, we have placed our three R&D centres at the heart of three internationally reputed scientific hubs: Paris-Saclay in France, Oxford in the United Kingdom and Cambridge in the United States, in contact with leading academic research centers, medical centers and biotechnology companies.

We make sure we access the best information and opportunities provided through external networks; the partnerships that we develop through the surrounding scientific ecosystems contribute strongly to our R&D success.

Opened in April 2015, the Ipsen Bioscience R&D center in Cambridge is dedicated to a “search & evaluate” model to enhance the pipeline with clinical assets across all three therapy areas, primarily Oncology and Rare Diseases. In addition, it hosts key functions essential to the delivery of clinical projects to market: the development team, tasked with coordinating and conducting clinical research in North America and a dedicated regulatory group which focuses on Ipsen’s regulatory activities with the FDA in the United States.

It is located in an exceptional environment of universities and academic institutions, within one of the largest global life sciences hubs. Ipsen’s researchers work in close proximity with top American universities and institutions (Harvard, Massachusetts Institute of Technology, etc.), prestigious hospitals and major players in pharmaceuticals, as well as pioneering start-ups, including some of Ipsen’s partners. The Cambridge facility positions Ipsen at the center of the biotech revolution, among the most exciting pioneers in the industry.

3

 

International R&D Centers

€200m

 

investment in R&D in 2016

Last update 13/10/2017